Skip to content

Study of Gut Microbiota in Crohn's Disease Patients Suffering From Spondylarthritis

Study of Gut Microbiota in Crohn's Disease Patients Suffering From Spondylarthritis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03072836
Acronym
FLORACROHN
Enrollment
108
Registered
2017-03-07
Start date
2017-03-06
Completion date
2020-12-15
Last updated
2020-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease, Spondyloarthritis

Brief summary

The FLORACROHN project aims to compare gut microbiota of patients suffering from Crohn's disease (CD) associated or not to spondylarthritis (SpA). 3 groups of patients will be analyzed: patients suffering from CD alone, patients suffering from SpA alone, patients suffering from CD and SpA. Fecal microbiota will be determined by 16SRNA gene sequencing.

Interventions

OTHERanalysing microbiota

16SRNA gene sequencing of feces

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with Crohn's disease and axial spondyloarthritis according to the criteria below. * Patients with Crohn's disease (CT patients) diagnosed according to clinical, biological, radiological, endoscopic and / or histological criteria for 3 months. With diagnosis of spondyloarthritis exclusion on modified ASAS and / or New York criteria. * Patients with axial spondyloarthritis (SpA patients) diagnosed according to the modified ASAS and / or New York criteria with exclusion diagnosis of Crohn's disease. * Patient with the capacity to give free and informed consent.

Exclusion criteria

Antecedent of colonic resection * Antibiotic or colonic colonoscopy preparation in the 8 weeks prior to stool collection (against temporary indication = collection possible before colic preparation or on the first saddle after the start of the colic preparation). * Ostomy at time of collection * BMI\> 30 * extreme diet * unbalanced diabetes * Patient under guardianship, under curatorship or under safeguard of justice

Design outcomes

Primary

MeasureTime frameDescription
Microbiota analysis6 months after last patient inclusion16SRNA gene sequencing

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026